The Prague Post - Formerra to Supply Foster Medical Compounds in Europe

EUR -
AED 4.179607
AFN 72.258895
ALL 94.205288
AMD 419.32538
ANG 2.037333
AOA 1043.471931
ARS 1673.878652
AUD 1.646164
AWG 2.049676
AZN 1.931828
BAM 1.955918
BBD 2.296329
BDT 140.068478
BGN 1.924085
BHD 0.43002
BIF 3405.606125
BMD 1.137919
BND 1.476989
BOB 7.895478
BRL 5.920364
BSD 1.140164
BTN 107.948534
BWP 15.503938
BYN 3.202194
BYR 22303.209908
BZD 2.293039
CAD 1.616971
CDF 2577.385877
CHF 0.922079
CLF 0.026365
CLP 1037.657169
CNY 7.709175
CNH 7.735322
COP 3899.04488
CRC 517.224487
CUC 1.137919
CUP 30.15485
CVE 110.271674
CZK 24.228625
DJF 202.230987
DKK 7.475001
DOP 66.733159
DZD 152.068092
EGP 56.580855
ERN 17.068783
ETB 183.814318
FJD 2.561791
FKP 0.85899
GBP 0.86289
GEL 3.009787
GGP 0.85899
GHS 12.797775
GIP 0.85899
GMD 83.067764
GNF 9990.121794
GTQ 8.698526
GYD 238.534437
HKD 8.922706
HNL 30.504712
HRK 7.534161
HTG 149.069022
HUF 355.706046
IDR 20399.24405
ILS 3.40957
IMP 0.85899
INR 107.8111
IQD 1493.5904
IRR 1564638.450732
ISK 144.003725
JEP 0.85899
JMD 179.470074
JOD 0.806818
JPY 183.853426
KES 147.258242
KGS 99.511194
KHR 4575.854724
KMF 490.443242
KPW 1024.127384
KRW 1745.914618
KWD 0.351594
KYD 0.950158
KZT 554.603568
LAK 25248.528174
LBP 102099.879625
LKR 381.463088
LRD 207.502559
LSL 18.801338
LTL 3.359979
LVL 0.688316
LYD 7.316411
MAD 10.671146
MDL 20.072215
MGA 4763.288299
MKD 61.63521
MMK 2388.932514
MNT 4072.611663
MOP 9.207457
MRU 45.285348
MUR 54.57472
MVR 17.592561
MWK 1977.010972
MXN 20.012811
MYR 4.711558
MZN 72.710706
NAD 18.801338
NGN 1558.857449
NIO 41.952539
NOK 11.148254
NPR 172.716695
NZD 2.008275
OMR 0.437534
PAB 1.140169
PEN 3.859434
PGK 5.000325
PHP 69.924546
PKR 317.102593
PLN 4.285607
PYG 6950.390134
QAR 4.156252
RON 5.247057
RSD 117.351293
RUB 84.774961
RWF 1671.993851
SAR 4.273217
SBD 9.177362
SCR 15.231046
SDG 683.318583
SEK 11.088575
SGD 1.476194
SHP 0.849571
SLE 28.163574
SLL 23861.593974
SOS 651.636577
SRD 42.652585
STD 23552.623219
STN 24.500299
SVC 9.976604
SYP 125.77656
SZL 18.795138
THB 37.854581
TJS 10.57484
TMT 3.994095
TND 3.374904
TOP 2.739836
TRY 52.886538
TTD 7.741469
TWD 36.036527
TZS 2987.455785
UAH 51.179898
UGX 4173.252587
USD 1.137919
UYU 45.732768
UZS 13698.829126
VES 701.942638
VND 29955.714328
VUV 135.137568
WST 3.136474
XAF 655.993822
XAG 0.018439
XAU 0.000276
XCD 3.075283
XCG 2.054824
XDR 0.815849
XOF 655.993822
XPF 119.331742
YER 271.564061
ZAR 18.840509
ZMK 10242.636979
ZMW 20.453238
ZWL 366.409413
  • RBGPF

    -0.2700

    60.34

    -0.45%

  • BCC

    -0.6300

    71.91

    -0.88%

  • CMSC

    -0.0400

    22.12

    -0.18%

  • BCE

    0.3800

    23.03

    +1.65%

  • AZN

    3.6000

    180.03

    +2%

  • BTI

    1.8200

    60.72

    +3%

  • CMSD

    -0.1000

    21.98

    -0.45%

  • GSK

    1.2350

    51.975

    +2.38%

  • NGG

    0.7700

    81.74

    +0.94%

  • JRI

    -0.0100

    12.64

    -0.08%

  • RELX

    0.2600

    31.09

    +0.84%

  • RIO

    -3.4800

    95.88

    -3.63%

  • VOD

    -0.0850

    14.035

    -0.61%

  • BP

    -0.3940

    39.386

    -1%

  • RYCEF

    -0.1500

    18.25

    -0.82%

Formerra to Supply Foster Medical Compounds in Europe
Formerra to Supply Foster Medical Compounds in Europe

Formerra to Supply Foster Medical Compounds in Europe

Expanded agreement infuses Formerra's European healthcare polymer portfolio with life-saving Foster® compounds.

Text size:

PUTNAM, CT AND ROMEOVILLE, IL / ACCESS Newswire / January 29, 2026 / Formerra and GEON® Performance Solutions today announced an agreement that designates Formerra as the preferred distributor of Foster®, LLC medical compounds in Europe. This adds to Formerra's current distribution of these materials in North and South America, enabling Formerra to now support customers who need the same product in all regions.

Following GEON's January 2025 acquisition of Foster, the agreement builds on Formerra's long-standing, global partnership with GEON for flexible and rigid PVC and filled polypropylene materials.

"Bringing Foster's medical-grade portfolio to Europe strengthens our ability to support healthcare manufacturers across the region with specialized compounds and the local expertise they need to navigate complex regulatory environments," said Kelly Wessner, Vice President, Key Accounts, Formerra. "Building on the momentum of our Americas partnership, we're excited to extend these proven solutions to European customers who demand the highest standards in medical device materials."

With more than 30 years in custom medical polymer compounding, Foster delivers highly engineered, top-of-the-polymer-pyramid formulations tailored to demanding requirements. The portfolio includes options such as radiopaque compounds and grades that meet USP Class VI requirements and align with ISO 10993 expectations. These materials support critical end uses across the healthcare space, including implantable products and other highly specialized applications.

"Extending our Foster portfolio into Europe with Formerra allows us to meet growing demand from healthcare manufacturers in one of the world's most dynamic medical device markets," said Arthur Adams, Chief Commercial Officer, GEON. "This expansion reinforces our shared commitment to supporting innovation in life-saving applications globally."

Adding Foster® compounds to its European portfolio will enable Formerra to better serve customers in the healthcare space, offering not only access to highly engineered medical polymers, but also deep regulatory expertise and responsive logistics across the region.

Formerra will exhibit at MD&M West in Booth 2266 in Anaheim, California, February 3-5, 2026.

###

Key Details

  • Formerra will distribute Foster® medical compounds in Europe.

  • This agreement adds custom medical-grade compounds to Formerra's existing global access to GEON® PVC and filled PP materials.

About Formerra
Formerra is a preeminent distributor of engineered materials, connecting the world's leading polymer producers with thousands of OEMs and brand owners across healthcare, consumer, industrial, and mobility markets. Powered by technical and commercial expertise, it brings a distinctive combination of portfolio depth, supply chain strength, industry knowledge, service, leading e-commerce capabilities, and ingenuity. The experienced Formerra team helps customers across multiple industries to design, select, process, and develop products in new and better ways - driving improved performance, productivity, reliability, and sustainability. To learn more, visit www.formerra.com.

About GEON Performance Solutions
GEON® Performance Solutions unlocks the power of polymers for the future. From biomedical materials from our medical division, Foster, LLC, to building materials, automotive, connectivity, and appliances, customers in these markets rely on the portfolio of compounding solutions, highly adaptable vinyl, polyolefin, engineered resin technologies, and full-service contract manufacturing that we deliver. In every formulation, collaboration, and challenge we're shaping the brilliance of tomorrow and providing a formidable advantage by engineering what's possible. Geon has approximately 1,200 global associates and 15 world-class manufacturing plants with headquarters in Westlake, Ohio. Learn more at www.geon.com. Geon is a portfolio company of SK Capital Partners.

Media Contact
Jackie Morris
Marketing Communications Manager, Formerra
[email protected]
+1 630-972-3144

SOURCE: Formerra



View the original press release on ACCESS Newswire

R.Rous--TPP